Medtronic Annoucnes New Data from Global SYMPLICITY Registry Affirm Strong Safety Profile
September 02, 2013 at 11:35 AM EDT
Medtronic, Inc. (NYSE: MDT ), announced today at the European Society of Cardiology (ESC) Congress, new data from the Global SYMPLICITY Registry that continue to affirm the strong safety profile of the Symplicity(TM) renal denervation system in a real-world patient population. Among the 1,158 patients analyzed in the registry
